iPSC Derived Cell Therapies for Cancer

Cell therapies derived from induced Pluripotent Stem Cell (iPSC) technology is emerging in cancer therapeutics. For example, iPSCs allow the development of immune therapies and drug screening programs in the genetic background of the patient. Discover the latest research on iPSC derived cell therapies for cancer here.

November 17, 2020
Open Access

Epigenetic Regulation of Cancer Stem Cell formation and maintenance

International Journal of Cancer. Journal International Du Cancer
Rhiannon French, Siim Pauklin
January 13, 2021
Open Access

Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies

International Journal of Molecular Sciences
Aleksandra MajewskaClaudine Kieda
November 13, 2020
Open Access

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells

Stem Cell Research & Therapy
Ratchapong NetsrithongMethichit Wattanapanitch
December 20, 2020
Open Access

Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel

Clinical and Translational Science
Chenling XiongDeanna L Kroetz
November 3, 2020
Open Access

Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms

Kasem KulkeawNarisara Whangviboonkij
November 24, 2020
Open Access

Gene edited fluorescent cerebral organoids to study human brain function and disease

BioRxiv : the Preprint Server for Biology
L. BachmannThorsten Mueller
November 22, 2020
Open Access

Ancestry-dependent gene expression correlates with reprogramming to pluripotency and multiple dynamic biological processes

Science Advances
Laura S BisognoTrevor K Archer
November 12, 2020
Open Access

Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis

Molecular Cell
Nathan K LeclairOlga Anczuków
January 4, 2021
Open Access

Telomerase therapy attenuates cardiotoxic effects of doxorubicin

Molecular Therapy : the Journal of the American Society of Gene Therapy
Shambhabi ChatterjeeChristian Bär
November 2, 2020

Mass-Production of Cytotoxic T Lymphocytes Regenerated from Pluripotent Stem Cells-To Target Solid Tumors

Gan to kagaku ryoho. Cancer & chemotherapy
Soki KashimaHiroshi Kawamoto
December 16, 2020
Open Access

Current and Future Perspectives of the Use of Organoids in Radiobiology

Peter W Nagle, Robert P Coppes
December 4, 2020
Open Access

Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines

Bruno Bernardes de JesusSandrina Nóbrega-Pereira
November 24, 2020

Regulation of platelet numbers and sizes by signaling pathways

Jaturawat PawinwongchaiPonlapat Rojnuckarin
November 11, 2020
Open Access

Cellular Reprogramming-A Model for Melanoma Cellular Plasticity

International Journal of Molecular Sciences
Karol GranadosJochen Utikal
January 6, 2021
Open Access

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

Mohit KumarSakthivel Sadayappan
November 17, 2020
Open Access

Regulation of breast cancer oncogenesis by the cell of origin's differentiation state

Sarah C PetrovaSanford H Barsky

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Brain Stem Neoplasms

Brain Stem Neoplasms are cancers that are common in children and can occur in the mesencephalon, pons or medulla oblongata. Discover the latest research on Brain Stem Neoplasms here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

© 2021 Meta ULC. All rights reserved